InsiderTrades.com logo

ORIC Insider Trading

Insider Ownership Percentage: 6.82%
Insider Buying (Last 12 Months): $262,976.12
Insider Selling (Last 12 Months): $3,791,740.79

Oric Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Oric Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Oric Pharmaceuticals Share Price & Price History

Current Price: $12.48
Price Change: ▼ Price Decrease of -0.4 (-3.11%)
As of 11/12/2025 05:00 PM ET

This chart shows the closing price history over time for ORIC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Oric Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/6/2025Dominic PiscitelliCFOSell11,000$14.52$159,720.0048,317View SEC Filing Icon  
10/6/2025Jacob ChackoCEOSell37,461$12.32$461,519.52531,419View SEC Filing Icon  
10/1/2025Jacob ChackoCEOSell53,001$12.05$638,662.05568,880View SEC Filing Icon  
9/30/2025Jacob ChackoCEOSell34,538$12.01$414,801.38621,881View SEC Filing Icon  
9/22/2025Jacob ChackoCEOSell125,000$10.80$1,350,000.00656,419View SEC Filing Icon  
6/24/2025Dominic PiscitelliCFOSell32,466$10.50$340,893.0068,317View SEC Filing Icon  
6/23/2025Angie YouDirectorBuy1,403$9.43$13,230.2928,000View SEC Filing Icon  
6/23/2025Dominic PiscitelliCFOSell1,034$10.00$10,340.00100,783View SEC Filing Icon  
6/20/2025Angie YouDirectorBuy26,597$9.39$249,745.8326,597View SEC Filing Icon  
6/12/2025Dominic PiscitelliCFOSell300$10.00$3,000.00101,817View SEC Filing Icon  
6/11/2025Dominic PiscitelliCFOSell2,976$10.01$29,789.76102,117View SEC Filing Icon  
6/10/2025Dominic PiscitelliCFOSell324$10.00$3,240.00105,093View SEC Filing Icon  
6/9/2025Dominic PiscitelliCFOSell300$10.00$3,000.00103,864View SEC Filing Icon  
6/6/2025Dominic PiscitelliCFOSell2,600$10.01$26,026.00104,164View SEC Filing Icon  
12/16/2024Dominic PiscitelliCFOSell8,851$8.28$73,286.28106,764View SEC Filing Icon  
12/16/2024Jacob ChackoCEOSell24,660$8.28$204,184.80778,648View SEC Filing Icon  
12/16/2024Pratik S. MultaniInsiderSell8,850$8.28$73,278.0046,765View SEC Filing Icon  
2/6/2024Jacob ChackoCEOSell13,958$12.12$169,170.96794,586View SEC Filing Icon  
12/15/2023Jacob ChackoCEOSell14,539$8.58$124,744.62808,544View SEC Filing Icon  
12/15/2023Pratik S. MultaniInsiderSell5,282$8.59$45,372.3823,809View SEC Filing Icon  
7/10/2023Jacob ChackoCEOSell10,508$8.01$84,169.08785,808View SEC Filing Icon  
7/5/2023Jacob ChackoCEOSell4,336$8.01$34,731.36796,316View SEC Filing Icon  
6/26/2023Jacob ChackoCEOSell20,000$8.03$160,600.00800,652View SEC Filing Icon  
12/15/2022Jacob ChackoCEOSell5,764$3.25$18,733.00817,025View SEC Filing Icon  
12/15/2022Pratik S. MultaniInsiderSell2,089$3.25$6,789.257,423View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Oric Pharmaceuticals (NASDAQ:ORIC)

95.05% of Oric Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ORIC by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Oric Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/12/2025Barclays PLC184,091$2.21M0.0%+29.0%0.190%Search for SEC Filing on Google Icon
11/12/2025Dimensional Fund Advisors LP793,871$9.52M0.0%+11.1%0.817%Search for SEC Filing on Google Icon
11/12/2025Legato Capital Management LLC23,396$0.28M0.0%N/A0.024%Search for SEC Filing on Google Icon
11/12/2025Royce & Associates LP1,458,483$17.50M0.2%+521.2%1.502%Search for SEC Filing on Google Icon
11/12/2025Rafferty Asset Management LLC85,592$1.03M0.0%+100.7%0.088%Search for SEC Filing on Google Icon
11/12/2025Intech Investment Management LLC17,383$0.21M0.0%-31.7%0.018%Search for SEC Filing on Google Icon
11/12/2025Fox Run Management L.L.C.16,887$0.20M0.0%N/A0.017%Search for SEC Filing on Google Icon
11/10/2025TD Asset Management Inc151,700$1.82M0.0%-14.6%0.156%Search for SEC Filing on Google Icon
11/10/2025Palumbo Wealth Management LLC44,026$0.53M0.1%-5.9%0.045%Search for SEC Filing on Google Icon
11/10/2025ANTIPODES PARTNERS Ltd2,901$35K0.0%-44.1%0.003%Search for SEC Filing on Google Icon
11/10/2025China Universal Asset Management Co. Ltd.27,024$0.32M0.0%+89.3%0.028%Search for SEC Filing on Google Icon
11/7/2025GSA Capital Partners LLP31,928$0.38M0.0%N/A0.033%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.4,650,138$55.80M0.0%+48.8%4.788%Search for SEC Filing on Google Icon
11/7/2025JPMorgan Chase & Co.1,228,528$14.74M0.0%-8.0%1.265%Search for SEC Filing on Google Icon
11/7/2025PNC Financial Services Group Inc.9,168$0.11M0.0%-26.6%0.009%Search for SEC Filing on Google Icon
11/6/2025Assetmark Inc.3,089$37K0.0%N/A0.003%Search for SEC Filing on Google Icon
11/6/2025Rhumbline Advisers82,031$0.98M0.0%+14.8%0.084%Search for SEC Filing on Google Icon
11/6/2025Profund Advisors LLC18,720$0.23M0.0%N/A0.019%Search for SEC Filing on Google Icon
11/6/2025ProShare Advisors LLC13,383$0.16M0.0%+12.9%0.014%Search for SEC Filing on Google Icon
11/5/2025Optimize Financial Inc39,044$0.47M0.2%N/A0.040%Search for SEC Filing on Google Icon
11/3/2025AlphaQuest LLC15,500$0.19M0.0%-23.1%0.016%Search for SEC Filing on Google Icon
11/3/2025Arizona State Retirement System10,056$0.12M0.0%N/A0.010%Search for SEC Filing on Google Icon
11/3/2025New York State Common Retirement Fund45,077$0.54M0.0%+153.4%0.046%Search for SEC Filing on Google Icon
11/3/2025Mirae Asset Global Investments Co. Ltd.3,755$45K0.0%+36.7%0.004%Search for SEC Filing on Google Icon
10/29/2025Wealth Enhancement Advisory Services LLC10,002$0.12M0.0%N/A0.010%Search for SEC Filing on Google Icon
10/28/2025Campbell & CO Investment Adviser LLC13,970$0.17M0.0%-29.0%0.014%Search for SEC Filing on Google Icon
10/23/2025SG Americas Securities LLC18,023$0.22M0.0%N/A0.019%Search for SEC Filing on Google Icon
10/23/2025KLP Kapitalforvaltning AS7,100$85K0.0%N/A0.007%Search for SEC Filing on Google Icon
10/22/2025Hennion & Walsh Asset Management Inc.147,048$1.77M0.1%-1.8%0.151%Search for SEC Filing on Google Icon
8/27/2025Squarepoint Ops LLC106,767$1.08M0.0%N/A0.110%Search for SEC Filing on Google Icon
8/15/2025Tower Research Capital LLC TRC 11,757$0.12M0.0%+1,293.0%0.012%Search for SEC Filing on Google Icon
8/15/2025Rafferty Asset Management LLC42,644$0.43M0.0%-44.9%0.044%Search for SEC Filing on Google Icon
8/15/2025Frazier Life Sciences Management L.P.1,065,334$10.81M0.4%-24.5%1.097%Search for SEC Filing on Google Icon
8/15/2025Eventide Asset Management LLC951,433$9.66M0.2%N/A0.980%Search for SEC Filing on Google Icon
8/15/2025EcoR1 Capital LLC1,618,068$16.42M1.0%-52.7%1.666%Search for SEC Filing on Google Icon
8/15/2025BNP Paribas Financial Markets86,755$0.88M0.0%+1,102.4%0.089%Search for SEC Filing on Google Icon
8/15/2025Brevan Howard Capital Management LP34,725$0.35M0.0%N/A0.036%Search for SEC Filing on Google Icon
8/15/2025Balyasny Asset Management L.P.1,777,744$18.04M0.0%-11.4%1.830%Search for SEC Filing on Google Icon
8/15/2025Bank of America Corp DE298,442$3.03M0.0%+14.9%0.307%Search for SEC Filing on Google Icon
8/15/2025Adage Capital Partners GP L.L.C.365,400$3.71M0.0%N/A0.376%Search for SEC Filing on Google Icon
8/15/2025Alkeon Capital Management LLC4,504,096$45.72M0.1%+12.5%4.638%Search for SEC Filing on Google Icon
8/15/2025Ameriprise Financial Inc.38,864$0.39M0.0%+7.5%0.040%Search for SEC Filing on Google Icon
8/14/2025MPM Bioimpact LLC1,729,378$17.55M3.0%+23.6%1.781%Search for SEC Filing on Google Icon
8/14/2025Orbimed Advisors LLC899,281$9.13M0.2%+28.5%1.055%Search for SEC Filing on Google Icon
8/14/2025Jane Street Group LLC46,711$0.47M0.0%+49.7%0.055%Search for SEC Filing on Google Icon
8/14/2025California State Teachers Retirement System2,800$28K0.0%-91.2%0.003%Search for SEC Filing on Google Icon
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.26,658$0.27M0.0%-33.7%0.031%Search for SEC Filing on Google Icon
8/14/2025The Manufacturers Life Insurance Company 124,108$1.26M0.0%-4.3%0.146%Search for SEC Filing on Google Icon
8/14/2025Squarepoint Ops LLC106,767$1.08M0.0%N/A0.125%Search for SEC Filing on Google Icon
8/14/2025OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC 49,000$0.50M0.0%+2.9%0.057%Search for SEC Filing on Google Icon
8/14/2025Stempoint Capital LP200,785$2.04M0.7%N/A0.236%Search for SEC Filing on Google Icon
8/14/2025Resolute Capital Asset Partners LLC227,515$2.31M1.2%N/A0.267%Search for SEC Filing on Google Icon
8/14/2025Vivo Capital LLC3,126,604$31.74M3.2%+50.3%3.669%Search for SEC Filing on Google Icon
8/13/2025Invesco Ltd.61,563$0.63M0.0%+52.3%0.072%Search for SEC Filing on Google Icon
8/13/2025New York State Common Retirement Fund17,792$0.18M0.0%-53.8%0.021%Search for SEC Filing on Google Icon
8/13/2025Virtus Investment Advisers LLC9,724$99K0.0%-50.1%0.011%Search for SEC Filing on Google Icon
8/12/2025Ameritas Investment Partners Inc.4,581$46K0.0%-24.1%0.005%Search for SEC Filing on Google Icon
8/12/2025American Century Companies Inc.91,210$0.93M0.0%-19.0%0.107%Search for SEC Filing on Google Icon
8/12/2025Rhumbline Advisers71,431$0.73M0.0%-19.5%0.084%Search for SEC Filing on Google Icon
8/12/2025Franklin Resources Inc.1,042,558$10.58M0.0%+1.9%1.223%Search for SEC Filing on Google Icon
8/12/2025Legal & General Group Plc4,339$44K0.0%-86.6%0.005%Search for SEC Filing on Google Icon
8/12/2025JPMorgan Chase & Co.1,335,448$13.56M0.0%+3,646.1%1.567%Search for SEC Filing on Google Icon
8/8/2025Intech Investment Management LLC25,447$0.26M0.0%-37.6%0.030%Search for SEC Filing on Google Icon
8/8/2025Creative Planning11,095$0.11M0.0%N/A0.013%Search for SEC Filing on Google Icon
8/8/2025Police & Firemen s Retirement System of New Jersey10,684$0.11M0.0%-13.7%0.013%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC1,108,460$11.25M0.0%-15.1%1.301%Search for SEC Filing on Google Icon
8/7/2025ProShare Advisors LLC11,856$0.12M0.0%-28.3%0.014%Search for SEC Filing on Google Icon
8/7/2025Monaco Asset Management SAM20,000$0.20M0.0%N/A0.023%Search for SEC Filing on Google Icon
8/7/2025Campbell & CO Investment Adviser LLC19,668$0.20M0.0%N/A0.023%Search for SEC Filing on Google Icon
8/5/2025ANTIPODES PARTNERS Ltd5,194$53K0.0%+35.9%0.006%Search for SEC Filing on Google Icon
7/31/2025Nisa Investment Advisors LLC2,436$25K0.0%+17,300.0%0.003%Search for SEC Filing on Google Icon
7/31/2025AlphaQuest LLC20,157$0.21M0.0%-52.8%0.024%Search for SEC Filing on Google Icon
7/28/2025TD Asset Management Inc177,700$1.80M0.0%+16.4%0.209%Search for SEC Filing on Google Icon
7/25/2025CWM LLC12,457$0.13M0.0%+303.0%0.015%Search for SEC Filing on Google Icon
7/15/2025Palumbo Wealth Management LLC46,783$0.48M0.1%N/A0.055%Search for SEC Filing on Google Icon
6/18/2025Voya Investment Management LLC16,885$94K0.0%-10.1%0.020%Search for SEC Filing on Google Icon
5/29/2025Rhumbline Advisers88,753$0.50M0.0%-4.9%0.125%Search for SEC Filing on Google Icon
5/19/2025Jane Street Group LLC31,198$0.17M0.0%+56.0%0.044%Search for SEC Filing on Google Icon
5/19/2025UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC509,179$2.84M0.0%+1,331.1%0.716%Search for SEC Filing on Google Icon
5/16/2025Fred Alger Management LLC178,722$1M0.0%-18.5%0.251%Search for SEC Filing on Google Icon
5/16/2025Goldman Sachs Group Inc.294,784$1.65M0.0%+9.2%0.346%Search for SEC Filing on Google Icon
5/16/2025Parkman Healthcare Partners LLC203,006$1.13M0.1%N/A0.286%Search for SEC Filing on Google Icon
5/16/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.40,201$0.23M0.0%+8.4%0.057%Search for SEC Filing on Google Icon
5/16/2025AQR Capital Management LLC49,530$0.28M0.0%N/A0.070%Search for SEC Filing on Google Icon
5/16/2025Alkeon Capital Management LLC4,004,096$22.34M0.0%+2.6%5.633%Search for SEC Filing on Google Icon
5/15/2025MPM Bioimpact LLC1,399,514$7.81M1.3%N/A1.969%Search for SEC Filing on Google Icon
5/15/2025Frazier Life Sciences Management L.P.1,410,193$7.87M0.4%-63.7%1.984%Search for SEC Filing on Google Icon
5/15/2025DAFNA Capital Management LLC242,000$1.35M0.4%N/A0.340%Search for SEC Filing on Google Icon
5/15/2025Tema Etfs LLC40,934$0.23M0.1%-10.0%0.058%Search for SEC Filing on Google Icon
5/15/2025Trexquant Investment LP76,093$0.43M0.0%N/A0.107%Search for SEC Filing on Google Icon
5/14/2025Rafferty Asset Management LLC77,424$0.43M0.0%+50.7%0.109%Search for SEC Filing on Google Icon
5/14/2025AlphaQuest LLC42,677$0.24M0.0%+50.1%0.060%Search for SEC Filing on Google Icon
5/14/2025Hsbc Holdings PLC17,983$0.10M0.0%N/A0.025%Search for SEC Filing on Google Icon
5/14/2025Wellington Management Group LLP178,217$0.99M0.0%-4.4%0.251%Search for SEC Filing on Google Icon
5/13/2025American Century Companies Inc.112,628$0.63M0.0%+4.4%0.158%Search for SEC Filing on Google Icon
5/12/2025Nuveen LLC167,502$0.94M0.0%N/A0.236%Search for SEC Filing on Google Icon
5/12/2025Invesco Ltd.40,419$0.23M0.0%+68.7%0.057%Search for SEC Filing on Google Icon
5/12/2025Vivo Capital LLC2,080,450$11.61M1.5%+62.8%2.927%Search for SEC Filing on Google Icon
5/12/2025Swiss National Bank68,400$0.38M0.0%+9.6%0.096%Search for SEC Filing on Google Icon
5/9/2025Deutsche Bank AG51,976$0.29M0.0%-9.5%0.073%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Oric Pharmaceuticals logo
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor, currently under Phase 1b study, which is designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations; ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer, currently under Phase 1b study; and ORIC-533, an orally bioavailable small molecule inhibitor of CD73, currently under Phase 1b study, being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens. The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms, including ORIC-613, an orally bioavailable, highly selective inhibitor of PLK4, in preclinical studies for the treatment of breast cancers. It has a license and collaboration agreement with Voronoi Inc.; a license agreement with Mirati Therapeutics, Inc.; and clinical development collaboration agreement with Pfizer Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California.
Read More on Oric Pharmaceuticals

Today's Range

Now: $12.48
Low: $12.39
High: $12.97

50 Day Range

MA: $12.14
Low: $10.41
High: $14.41

52 Week Range

Now: $12.48
Low: $3.90
High: $14.93

Volume

866,219 shs

Average Volume

1,168,599 shs

Market Capitalization

$1.21 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.66

Who are the company insiders with the largest holdings of Oric Pharmaceuticals?

Oric Pharmaceuticals' top insider shareholders include:
  1. Jacob Chacko (CEO)
  2. Dominic Piscitelli (CFO)
  3. Pratik S Multani (Insider)
  4. Angie You (Director)
Learn More about top insider investors at Oric Pharmaceuticals.

Who are the major institutional investors of Oric Pharmaceuticals?

Oric Pharmaceuticals' top institutional investors include:
  1. Vanguard Group Inc. — 4.79%
  2. JPMorgan Chase & Co. — 1.26%
  3. TD Asset Management Inc — 0.16%
  4. Hennion & Walsh Asset Management Inc. — 0.15%
  5. Rhumbline Advisers — 0.08%
  6. New York State Common Retirement Fund — 0.05%
Learn More about top institutional investors of Oric Pharmaceuticals stock.

Which institutional investors are selling Oric Pharmaceuticals stock?

During the last quarter, ORIC stock was sold by these institutional investors:
  1. JPMorgan Chase & Co.
  2. TD Asset Management Inc
  3. Intech Investment Management LLC
  4. Campbell & CO Investment Adviser LLC
  5. AlphaQuest LLC
  6. PNC Financial Services Group Inc.
  7. Palumbo Wealth Management LLC
  8. Hennion & Walsh Asset Management Inc.
In the previous year, company insiders that have sold Oric Pharmaceuticals company stock include:
  1. Jacob Chacko (CEO)
  2. Dominic Piscitelli (CFO)
  3. Pratik S Multani (Insider)
Learn More investors selling Oric Pharmaceuticals stock.

Which institutional investors are buying Oric Pharmaceuticals stock?

During the previous quarter, ORIC stock was bought by institutional investors including:
  1. Vanguard Group Inc.
  2. Optimize Financial Inc
  3. GSA Capital Partners LLP
  4. New York State Common Retirement Fund
  5. Profund Advisors LLC
  6. SG Americas Securities LLC
  7. Fox Run Management L.L.C.
  8. China Universal Asset Management Co. Ltd.